Across TCGA pan-cancer cohorts, SNORA41B RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated SNORA41B data layer.
The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher SNORA41B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORA41B expression acts as an unfavorable survival marker.
SKCM, THYM, and THCA are the cancer types where SNORA41B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.